4SC AG INH. O.N./ DE000A3E5C40 /
2024-06-05 8:00:11 AM | Chg. 0.000 | Volume | Bid5:30:00 PM | Ask5:30:00 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
8.020EUR | 0.00% | 0 Turnover: 0.000 |
7.900Bid Size: 100 | 8.060Ask Size: 100 | 81.92 mill.EUR | 0.00% | - |
GlobeNewswire
2023-12-05
Thermosome Appoints Dr. Frank Hermann, MD, as Chief Medical Officer and Adds Prof. Alessandro Gronch...
GlobeNewswire
2019-04-01
Dynavax’s SD-101 and 4SC’s Domatinostat Demonstrate Synergy and Induce a Systemic Anti-tumor Respons...
GlobeNewswire
2018-06-11
Global Pharma and Biotech Discovery Stage Partnering Terms and Agreements Directory 2012-2018